Inventors with similar research interests:
Location History:
- Millton, VT (US) (2013)
- Cranford, NJ (US) (1990 - 2014)
- Milton, VT (US) (2011 - 2016)
Company Filing History:
50 out of 1,829 
4 out of 2,405 
1 out of 28 
Years Active: 1990-2016
Areas of Expertise:
Title: The Inventive Journey of John W Clader
Introduction:
John W Clader, a prolific inventor based in Cranford, NJ, has made significant contributions in the field of pharmaceuticals with a remarkable portfolio of 59 patents. His innovative spirit and dedication to improving healthcare have led to groundbreaking inventions that are shaping the future of medicine.
Latest Patents:
Among his latest patents is the development of bridged and fused antidiabetic compounds. These compounds serve as agonists of the G-protein coupled receptor 40 (GPR40), playing a vital role in regulating insulin levels in mammals. The compounds hold promise in the prevention and treatment of Type 2 diabetes mellitus and related conditions such as insulin resistance, obesity, and lipid disorders. Additionally, John W Clader has pioneered gamma secretase modulators, novel compounds that modulate gamma secretase activity and show potential in treating Alzheimer's Disease.
Career Highlights:
Throughout his illustrious career, John W Clader has worked with esteemed pharmaceutical companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His expertise and innovative mindset have led to the development of groundbreaking pharmaceutical compounds that have the potential to revolutionize the healthcare industry.
Collaborations:
Collaboration plays a crucial role in the world of innovation, and John W Clader has had the privilege of working alongside talented individuals like Duane A Burnett and Hubert B Josien. Together, they have synergized their skills and knowledge to drive forward groundbreaking research and development in the field of pharmaceuticals.
Conclusion:
In conclusion, John W Clader stands as a trailblazing inventor whose dedication to innovation and healthcare has resulted in a remarkable portfolio of patents. His groundbreaking work in developing antidiabetic compounds and gamma secretase modulators highlights his commitment to advancing medicine and improving the lives of individuals worldwide. John W Clader's contributions will continue to inspire future generations of inventors and propel the healthcare industry towards new frontiers.